BD expands syringe, needle production capacity in Nebraska and Connecticut
BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
Assembly Mag3d
Becton Dickinson Boosts U.S. Manufacturing of Critical Medical Devices
Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...
MassDevice10d
BD increases U.S. syringe, IV catheter manufacturing
BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...
Becker's Hospital Review9d
BD to expand production of critical medical devices
Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.
GlobalData on MSN3d
Carilion to use BD’s needle-free blood draw device
Not-for-profit healthcare organisation Carilion Clinic is set to provide needle-free blood draws to patients leveraging ...
pharmaphorum2y
BD partners with Biocorp on connected self-injection devices
BD is one of the top suppliers of prefilled syringes to the pharma industry, with more than a billion UltraSafePlus devices used in around 40 different products since it was first launched in 2010.
healthcarepackaging8d
RFID-enabled Digital ID Solution for Prefilled Syringe Traceability
Avery Dennison, in partnership with Turck Vilant Systems & Becton, Dickinson and Company, introduces BD iDFill Individual ...
Oral Syringes Industry Eyes $1.05 Billion Opportunity by 2030: Baxter, BD, Medtronic, Terumo Medical Corp, and Braun Lead the Competition
The Clear Oral Syringes Segment Held the Largest Share in 2024, Accounting for 62.9% of Total Revenues Oral Syringes Market ...
Becton Dickinson announces additional investments in manufacturing
Becton Dickinson (BDX) announced additional investments in its U.S. manufacturing network to add capacity for medical devices, including ...
Becton Dickinson Ramps Ups Medical Device Production for FY25
Overall, BD is expected to increase its production of domestically manufactured safety-engineered injection devices by more than 40% and conventional syringes by more than 50%. The manufacturer has ...